Weston Nichols, 10% Owner at Cullinan Therapeutics, Inc. (CGEM), bought 331,334 shares at $8.40 ($2.8M) on 2025-10-28, disclosed to the SEC on 2025-10-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.40 | 165,667 | $1.4M | 50.0% |
| 2 | $8.40 | 165,667 | $1.4M | 50.0% |
| Total | $8.40 avg | 331,334 | $2.8M | 100% |
| Filing → |
| TCRX | BUY | 2024-11-19 | $4K | — | Filing → |